In addition, a nationwide cohort study [63] that involved 62,250 patients with schizophrenia analyzed 29 different APM and APP treatment types for 10 years, and indicated that the risk of psychiatric readmission was lower in patients treated by APP with clozapine and aripiprazole than in those treated by APM with clozapine, which was the lowest in the cohort. Here, APP is linked to schizophrenia.